Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

28.57
-1.0150-3.43%
Volume:5.37M
Turnover:155.51M
Market Cap:6.66B
PE:-45.85
High:29.87
Open:29.28
Low:28.43
Close:29.58
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:212.45M
Volume Ratio:0.53
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:20.57
PE(LYR):55.76

Loading ...

Hims & Hers price target raised to $30 from $25 at BofA

TIPRANKS
·
Apr 22

Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Hims & Hers Health (HIMS) and UnitedHealth (UNH)

TIPRANKS
·
Apr 22

Stock Track | Hims & Hers Health Soars 5.61% Amid FDA Regulatory Optimism and Competitive Pressures

Stock Track
·
Apr 22

Mixed options sentiment in Hims and Hers Health with shares down 4.05%

TIPRANKS
·
Apr 22

Amazon GLP-1 Program Pressures Hims & Hers Stock

Benzinga_recent_news
·
Apr 22

Amazon on-demand option not a replacement for platforms like Hims, says Citi

TIPRANKS
·
Apr 22

Amazon (AMZN) Steps Up Weight Loss Push, Knocks HIMS Stock Off the Scale

TIPRANKS
·
Apr 21

Stock Track | Hims & Hers Health Plummets 7.85% Intraday as Investors Take Profits After FDA-Driven Rally

Stock Track
·
Apr 21

Option Movers | Beyond Meat Sees 92% Call Options; Ondas Holdings's $11 Call Soars 185%

Option Movers
·
Apr 21

Hims & Hers CFO Oluyemi Okupe disposes of shares worth $1.46 million

Reuters
·
Apr 21

Bullish flow in Hims and Hers Health with shares up 8.9%

TIPRANKS
·
Apr 21

Hims & Hers Health Soars over 8% on FDA Peptide Deregulation and Novo Nordisk Partnership

Stock Track
·
Apr 20

Stock Track | Hims & Hers Health Soars 9.74% Intraday on FDA Peptide Deregulation and Novo Nordisk Partnership

Stock Track
·
Apr 17

Option Movers | AMD's $270 Call Soars 1062%; Hims & Hers Sees 80% Call Options

Option Movers
·
Apr 17

Review & Preview: 12 Days of Nasdaq Gains -- Barrons.com

Dow Jones
·
Apr 17

Hims & Hers Stock Rises Thursday on Regulatory Development

Deep News
·
Apr 17

Stock Track | Hims & Hers Health Soars 11.14% Intraday on FDA Peptide Regulation Easing and Novo Nordisk Partnership

Stock Track
·
Apr 17

BofA Securities Lifts Price Target on Hims & Hers Health to $25 From $21, Maintains Neutral Rating

MT Newswires Live
·
Apr 16

Hims & Hers Health Inc : Bofa Global Research Raises Price Objective to $25 From $21

THOMSON REUTERS
·
Apr 16

S&P 500 Hits Fresh Record; Hims Jumps as RFK Jr. Seeks to Loosen Peptide Regulations

Tiger Newspress
·
Apr 16